Resistance Training Fights Brain Aging and Inflammation With the Right Dose

As the global population ages, finding scalable interventions to combat chronic inflammation and cognitive decline becomes increasingly urgent. Resistance training has long been proposed as a tool to address both, but the optimal training parameters have remained poorly defined — until now.

This systematic review and meta-analysis, published in Ageing Research Reviews, screened over 8,300 articles and included 36 high-quality randomized controlled trials involving older adults. Researchers examined how different doses of resistance training — including duration, frequency, intensity, volume, and rest periods — affected circulating biomarkers of inflammation and neuroplasticity.

The results were striking on both fronts. Resistance training significantly increased neuroplasticity-related biomarkers including BDNF, IGF-1, and FGF-21 with a moderate effect size of 0.51. Greater gains were achieved with programs lasting 20 or more weeks, incorporating eight or more exercises, higher training volumes, and rest intervals of 90–120 seconds between exercises. Separately, resistance training significantly reduced pro-inflammatory markers — TNF-α, IL-6, IL-1β, CRP, KYN, and CAF — with a large effect size of 0.66. These anti-inflammatory effects were most pronounced at training intensities of at least 70% of one-rep maximum and a frequency of three or more sessions per week. Anti-inflammatory biomarkers like IL-10, IL-13, and IL-4 also increased meaningfully.

For clinicians and trainers working with older populations, these findings offer a rare level of prescriptive specificity. The data suggest that high-volume, high-frequency, high-intensity resistance training programs of at least 20 weeks duration represent the optimal strategy for biological rejuvenation at the molecular level.

Caveats include the limited number of studies examining anti-inflammatory biomarker dose-response, which prevented firm conclusions in that domain. Risk of bias across included RCTs and variability in biomarker measurement methods also warrant cautious interpretation.